VILTICA-U 25 mcg+100 mcg+62.5 mcg Renacap contains Glycopyrronium 25 mcg + Budesonide 100 mcg + Indacaterol 62.5 mcg. It is a triple-combination inhalation medicine containing a long-acting muscarinic antagonist (LAMA), an inhaled corticosteroid (ICS), and a long-acting beta₂-agonist (LABA). It works by relaxing the airway muscles, reducing inflammation in the lungs, and improving airflow for easier breathing.
Uses:
-
Maintenance treatment of chronic obstructive pulmonary disease (COPD).
-
Maintenance treatment of asthma in patients requiring triple inhalation therapy, as prescribed by a physician.
-
Helps relieve symptoms such as:
-
Shortness of breath
-
Wheezing
-
Chest tightness
-
Chronic cough
-
Helps reduce the frequency of COPD and asthma exacerbations.
-
Not intended for the relief of sudden asthma or COPD attacks.
Dose:
-
Adults: Usually inhale the contents of 1 Renacap once daily or as directed by a physician.
-
For inhalation use only; do not swallow the capsule.
-
Use the capsule only with the recommended inhalation device.
-
Rinse your mouth with water after each inhalation to help reduce the risk of oral fungal infection (thrush).
-
Use regularly at the same time each day for the best therapeutic effect.
-
Do not stop or change the dose without medical advice.